7/24 FINANCE
TREN
BIST10014.321,19▼ 0.00%Golf's Quiet Surge: Genesis Scottish Open and Amundi Evian Championship Drive Short-Term Performance and Economic ImpactUSD/TRY47.1453▲ 0.20%SK Hynix U.S. Listing Challenges DRAM ETF Dominance: Is the Memory Chip War Entering a New Era?EUR/TRY53.6612▲ 0.30%Spain Defeats Belgium to Set Up Quarterfinal Clash with FranceBTC/USD$64,051.51▲ 1.24%eBay Q2 Expectations and Growth Trajectory: Can High-Margin Strategy Satisfy Investors?GOLD6.231,67▲ 0.15%New Regulation on Teaching Hours in MEB: Restructuring Public Sector WorkloadBRENT$76.00▼ 0.00%SK Hynix's $64.4 Billion Investment and $29 Billion Wall Street Debut: Strategic Moves in AI MemoryApple's Legal Action Against OpenAI: A Corporate Espionage Case with Sector-Wide ImplicationsBIST10014.321,19▼ 0.00%Golf's Quiet Surge: Genesis Scottish Open and Amundi Evian Championship Drive Short-Term Performance and Economic ImpactUSD/TRY47.1453▲ 0.20%SK Hynix U.S. Listing Challenges DRAM ETF Dominance: Is the Memory Chip War Entering a New Era?EUR/TRY53.6612▲ 0.30%Spain Defeats Belgium to Set Up Quarterfinal Clash with FranceBTC/USD$64,051.51▲ 1.24%eBay Q2 Expectations and Growth Trajectory: Can High-Margin Strategy Satisfy Investors?GOLD6.231,67▲ 0.15%New Regulation on Teaching Hours in MEB: Restructuring Public Sector WorkloadBRENT$76.00▼ 0.00%SK Hynix's $64.4 Billion Investment and $29 Billion Wall Street Debut: Strategic Moves in AI MemoryApple's Legal Action Against OpenAI: A Corporate Espionage Case with Sector-Wide Implications
Global Markets

Evercore ISI Raises Twist Bioscience (TWST) Price Target to $102 Amid AI-Driven Momentum and Risk-On Dynamics

724FinanceBora Yalın
Evercore ISI Raises Twist Bioscience (TWST) Price Target to $102 Amid AI-Driven Momentum and Risk-On Dynamics

Evercore ISI has increased its price target for Twist Bioscience (NASDAQ:TWST) to $102, while unexpectedly downgrading the stock to 'In Line' from 'Outperform,' signaling caution amid risk-on investor sentiment. In a July 6 analysis, the firm highlighted TWST's year-to-date surge of over 200%, with 85% of gains occurring post its May 21 analyst day, driven by optimism around AI-powered order momentum. Evercore ISI noted profit-taking behavior, urging investors to reassess risk-focused positions. Earlier in June, Guggenheim and Barclays also raised TWST's price targets to $107 and $95 respectively, citing growing demand in life science tools. Despite this, the report emphasizes AI-focused equities with higher upside potential and redirects attention to a 'deeply undervalued' AI stock aligned with Trump-era tariffs and reshoring trends. While TWST's synthetic DNA product line remains in high demand, the sustainability of its rally faces scrutiny.

Bora Yalın's Note: Analyst actions like these underscore how AI-integrated biotech stocks reflect both speculative enthusiasm and fundamental scrutiny. TWST's price target hike signals investor confidence in AI-driven tools amid reshoring trends, yet Evercore ISI's downgrade to 'In Line' suggests that sustained outperformance hinges on operational execution. The interplay between AI momentum and life sciences underscores a critical juncture for capital allocation in niche biotech segments.
Bora Yalın

Financial Analyst: Bora Yalın

Uluslararası Sermaye Akımları (Capital Flows) Baş Araştırmacısı. Risk-on / Risk-off döngülerini, hedge fonların küresel pozisyonlanmalarını ve likidite krizlerini inceleyen makro-finansal uzman.

Disclaimer: The investment information, comments, and recommendations contained herein are not within the scope of investment advisory. Investment advisory services are provided individually by authorized institutions, taking into account the risk and return preferences of individuals. The comments and recommendations contained herein are general in nature. These recommendations may not be suitable for your financial situation and your risk and return preferences. Therefore, making an investment decision based solely on the information contained herein may not produce results that meet your expectations.

© 2026 724Finance - All Rights Reserved.Original Source: Finance.yahoo.com